Clinically undetectable Plasmodium relapse infections may still pose a threat

Nonhuman primates with clinically undetectable Plasmodium relapse infections still harbor parasitic gametocytes that may be infectious to mosquitoes, according to a study published September 19 in the open-access journal PLOS Pathogens by F. Eun-Hyung Lee and Mary R. Galinski of Emory University, Tracey J. Lamb of the University of Utah, and colleagues. The study has important epidemiological implications relevant to malaria elimination strategies.

The protozoal parasite Plasmodium vivax is a major cause of malaria – a life-threatening mosquito-borne disease responsible for hundreds of thousands of deaths globally each year. P. vivax remains a major obstacle for malaria elimination due to its ability to form dormant stages in the liver. These forms can become activated to cause relapsing blood-stage infections. Relapses remain poorly understood because it is difficult to verify whether P. vivax blood-stage infections in patients are due to new infections or relapses. To address this gap in knowledge, researchers used a nonhuman primate model of malaria, combined with state-of-the-art immunological and molecular techniques, to assess pathogenesis, host responses, and circulating gametocyte levels during relapses.

They found that relapses were clinically silent compared to initial infections, and they were associated with a robust memory B cell response. This response resulted in the production of antibodies that were able to mediate clearance of relapsing, asexual parasites. Despite this rapid immune protection, the sexual-stage gametocytes, which may be infectious to mosquitoes, continued to circulate. According to the authors, the number of clinically silent relapse infections, and their infectiousness to mosquitoes, remains largely unknown and should be evaluated carefully in the future. As a next step on the path to eliminating P. vivax and other relapsing malaria parasites, studies should identify the factors that influence relapse pathogenesis, immunity, and infectiousness to mosquitoes.

This study shows the explicit benefit of using a nonhuman primate model system to study the immune response and relate the findings to human clinical cases and transmission. It is important to know that asymptomatic individuals may carry infectious gametocytes."

Dr. Mary R. Galinski, Emory University

Dr. Lamb adds, “This study reveals the role of B cells in the control of relapsing malaria.”

Finally Dr. Lee adds, “The nonhuman primate model is ideal to study the true memory B cell responses during relapsing malaria because this question is difficult to answer in human studies.”

Journal reference:

Joyner, C.J. et al. (2019) Humoral immunity prevents clinical malaria during Plasmodium relapses without eliminating gametocytes. PLOS Pathogens.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PLOS ONE. (2019, September 17). Clinically undetectable Plasmodium relapse infections may still pose a threat. News-Medical. Retrieved on April 16, 2024 from

  • MLA

    PLOS ONE. "Clinically undetectable Plasmodium relapse infections may still pose a threat". News-Medical. 16 April 2024. <>.

  • Chicago

    PLOS ONE. "Clinically undetectable Plasmodium relapse infections may still pose a threat". News-Medical. (accessed April 16, 2024).

  • Harvard

    PLOS ONE. 2019. Clinically undetectable Plasmodium relapse infections may still pose a threat. News-Medical, viewed 16 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rotavirus infection may play a role in type 1 diabetes development